Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PBAX

Phoenix Biotech Aquisition (PBAX)

Phoenix Biotech Aquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PBAX
DateTimeSourceHeadlineSymbolCompany
15/02/202408:48Business WirePhoenix Biotech Acquisition Corp. and CERo Therapeutics, Inc. Announce Close of Business CombinationNASDAQ:PBAXPhoenix Biotech Aquisition Corporation
07/06/202320:05Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
05/06/202323:27Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
05/06/202322:00Business WireCERo Therapeutics, Inc. and Phoenix Biotech Acquisition Corp. Announce Merger Agreement to Create Public Company Advancing the Development of Next Generation Engineered T Cell TherapeuticsNASDAQ:PBAXPhoenix Biotech Aquisition Corporation
13/05/202306:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
24/03/202321:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
15/02/202307:46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
15/02/202305:52Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
14/02/202322:11Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
25/01/202323:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
21/12/202208:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
08/12/202208:08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
08/12/202208:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
22/11/202200:39Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
11/11/202208:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
05/11/202207:07Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
01/11/202200:29Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
01/11/202200:27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
12/08/202206:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
14/05/202206:12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
25/03/202207:13Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
12/02/202208:51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
09/02/202208:06Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
04/02/202200:22Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
23/11/202108:15GlobeNewswire Inc.Phoenix Biotech Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on November 26, 2021NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
09/10/202107:00GlobeNewswire Inc.Phoenix Biotech Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment OptionNASDAQ:PBAXPhoenix Biotech Aquisition Corporation
06/10/202108:19GlobeNewswire Inc.Phoenix Biotech Acquisition Corp. Announces Pricing of $155,000,000 Initial Public OfferingNASDAQ:PBAXPhoenix Biotech Aquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:PBAX